Privacy settings and cookie consent

We value your privacy

We use cookies to analyze website usage and improve it. Some cookies are necessary for the website to function and cannot be switched off. Other cookies help us measure performance and collect anonymous data. You can opt in or opt out of specific non-essential cookies below.

Cookie Preferences
Privacy Policy External link Opens in a new window

Skip to content

Columbia University Irving Medical Center
Pathology Pathology
  • Faculty Directory
  • News
  • Events
  • Contact Us
  • Search
  • About Us

    About Us

    • Faculty Directory
    • Administration
    • Contact Us
    • News
    • Events
    • Department History
    • Anatomical Donor Program
    • Working at Pathology
  • Diagnostic Specialties

    Diagnostic Specialties

    • Laboratory Medicine Division
    • Anatomic Pathology Division
    • Personalized Genomic Medicine
  • Client and Patient Support

    Client and Patient Support

    • Laboratory Permits and Accreditations
    • Patient Billing Services
  • Research

    Research

    • ​Basic Research
    • Clinical and Translational Research
    • Research Labs
    • Pathology Research Administration

    Digital and Computational Pathology Lab

    Microscopic image showing blue-stained circular and irregular patterns.

    The DCPL performs acquisitions of high-resolution tissue slide images using bright field and fluorescence scanners to facilitate pathology research.

    Visit DCPL
  • Education

    Education

    • Residency Program
    • Clinical Fellowships
    • Medical and Dental Student Teaching
    • Graduate Program in Pathobiology and Mechanisms of Disease
    • Pathway Programs at Pathology and Cell Biology
    • Shelanski Research Innovation Award in Pathology
  • Make a Gift

You are here

  1. Home >
  2. Diagnostic Specialties >
  3. Personalized Genomic Medicine >
  4. Oncology Testing >
  5. Methylguanine-DNA Methyltransferase (MGMT) Assay

Personalized Genomic Medicine

  • Genetic Testing
  • Medical Microbiology Testing
  • Oncology Testing
    • BCR-ABL1 Quantitative Test by PCR
    • Cancer Whole Exome Sequencing with Transcriptome
    • Columbia Combined Cancer Panel (CCCP)
    • Columbia Solid Tumor (CSTP) Subpanels
    • Columbia Solid Tumor Panel (CSTP)
    • Columbia Targeted Fusion Panel (CTFP)
    • Darwin OncoTarget™/OncoTreat™
    • FLT3-ITD/NPM1
    • Immunoglobulin Heavy Chain Gene Rearrangement by PCR
    • Methylguanine-DNA Methyltransferase (MGMT) Assay
    • Microsatellite Instability Determination by PCR
    • Myeloproliferative Neoplasm (MPN) Panel
    • T-Cell Receptor Gene Rearrangement by PCR
    • Targeted Lymphoid Panel (TLP)
    • Targeted Myeloid Panel (TMP)
  • Sohn Precision Medicine Program at Columbia University

Methylguanine-DNA Methyltransferase (MGMT) Assay

Purpose

Detects MGMT promoter methylation by real-time PCR to aid in therapeutic decision in individuals with glioblastoma.

CPT Codes

81287

Methodology

PCR on DNA extracted from tumor and normal (with microdissection if necessary) followed by Capillary Electrophoresis

Turnaround Time

14 days

Samples Tested

Paraffin embedded tissue

Forms

  • PGM Oncology Requisition(link is external and opens in a new window)
  • Medicare Advance Beneficiary Notice(link is external and opens in a new window)
Columbia University Irving Medical Center
NewYork-Presbyterian(link is external and opens in a new window)
ColumbiaDoctors
  • About Us
  • Client and Patient Support
  • Diagnostic Specialties
  • Education
  • Research
  • PathConnect(link is external and opens in a new window)
  • Faculty Directory
  • News
  • Events
  • Make a Gift
  • Working at Pathology
  • Contact Us

Columbia University

630 West 168th Street
New York, NY 10032
United States

Follow Us

  • Instagram(link is external and opens in a new window)
  • YouTube(link is external and opens in a new window)
  • LinkedIn(link is external and opens in a new window)
  • Twitter(link is external and opens in a new window)
  • © 2025 Columbia University
  • Privacy Policy
  • Terms and Conditions
  • HIPAA
  • General Information: 212-305-2862
Back to top